Though there are few studies from Western countries [11,13,14] and other parts of the world [15] on the prediction and prevalence of NUP98::NSD1 in AML patients, nevertheless, the prevalence of this fusion protein remains unknown in Indian AML patients, possibly due to the non-availability of reliable screening methods. This evidence concerns the gene NUP98 and acute myeloid leukemia.